Table 3.
Final validity, feasibility and relevance ratings from the ExpertLens panel on the 11 cardiovascular quality indicators (QI)
| Quality Indicator | Validity | Feasibility | Relevance | Use of QI for local improvement | Disagreement* in any of the domains (Y/N) |
|---|---|---|---|---|---|
|
| |||||
| Median Rating (Min-Max) % Agreement (Rating>=7) | |||||
| 1. Communication of increased CVD risk in RA | 8.0 (4–9) | 8.0 (5–9) | 8.0 (5–9) | 8.0 (1–9) | N |
| 88.9% | 85.7% | 92.9% | 82.1% | ||
| 2. CVD risk assessment | 8.0 (5–9) | 7.0 (3–9) | 7.0 (3–9) | 7.5 (3–9) | N |
| 85.7% | 67.9% | 88.9% | 67.9% | ||
| 3. Smoking status and cessation counseling | 9.0 (6–9) | 8.5 (6–9) | 8.5 (6–9) | 9.0 (5–9) | N |
| 96.4% | 92.9% | 100% | 92.9% | ||
| 4. Screening for hypertension | 9.0 (5–9) | 9.0 (7–9) | 9.0 (7–9) | 9.0 (7–9) | N |
| 96.4% | 100% | 96.4% | 100% | ||
| 5. Communication to PCP about a documented high BP | 9.0 (7–9) | 9.0 (7–9) | 9.0 (7–9) | 9.0 (4–9) | N |
| 100% | 100% | 100% | 92.6% | ||
| 6. Measurement of a lipid profile | 7.5 (4–9) | 8.0 (4–9) | 8.0 (4–9) | 8.0 (3–9) | N |
| 82.1% | 89.3% | 85.7% | 82.1% | ||
| 7. Screening for diabetes | 8.0 (4–9) | 8.0 (4–9) | 8.0 (4–9) | 8.0 (3–9) | N |
| 89.3% | 82.1% | 92.9% | 85.2% | ||
| 8. Exercise | 8.0 (6–9) | 8.0 (5–9) | 8.0 (5–9) | 8.0 (3–9) | N |
| 96.4% | 85.7% | 89.3% | 77.8% | ||
| 9. BMI screening and lifestyle counseling | 8.0 (4–9) | 8.0 (4–9) | 8.0 (4–9) | 7.0 (3–9) | N |
| 89.3% | 78.6% | 92.9% | 85.7% | ||
| 10. Minimizing corticosteroid usage | 9.0 (5–9) | 8.0 (4–9) | 8.0 (4–9) | 8.5 (1–9) | N |
| 92.9% | 85.7% | 92.9% | 85.7% | ||
| 11. Communication about risks/benefits of anti-inflammatories in patients at high risk of CV events | 8.0 (4–9) | 7.0 (3–9) | 7.0 (3–9) | 7.0 (1–9) | N |
| 85.2% | 78.6% | 85.7% | 75.0% | ||
The results presented are those obtained from the 28 participants who completed both Round 1 and Round 3 of online voting. Possible range of scores is 1–9.
Disagreement measured using the Interpercentile Range greater than the Interpercentile range adjusted for symmetry (IPR>IPRAS) (29). Disagreement exists when the Interpercentile Range (IPR) (difference between the 30th and 70th percentiles) is larger than the Interpercentile Range Adjusted for Symmetry (IPRAS), which was calculated using the following formulae: IPRAS=2.35+[Asymmetry Index (AI)*1.5]
CVD: Cardiovascular Disease, BMI: Body Mass Index, BP: blood pressure, PCP: primary care physician, RA: rheumatoid arthritis